ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.254,27
1,01%
S&P 500
6.086,37
0,61%
Dow Jones
44.156,73
0,30%
Euro vs US Dollar
1,0412
0,04%
Bitcoin
102.000,34
-1,58%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Abivax SA (ABVX) Börsenkurse

Abivax SA

Abivax SA (ABVX)

Abivax
6,23
-0,14
(-2,20%)
Geschlossen 23 Januar 10:00PM
Verzögert um 15 Minuten
6,23
0,00
(0,00%)
Nach Börsenschluss: 12:01AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
6,23
Gebot
2,54
Fragen
10,14
Volumen
61.737
6,17 Tagesbereich 6,55
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
391,976M
Handelsende
6,37
Handelsbeginn
6,34
Letzte Trade
75
@
6.25
Letzter Handelszeitpunkt
Finanzvolumen
US$ 389.260
VWAP
6,3051
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
62.917.479
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,64
Gewinn pro Aktie (EPS)
-2,35
Erlöse
4,62M
Nettogewinn
-147,74M

Über Abivax SA

Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.abivax.com
Hauptsitz
Paris, Paris, Fra
Gegründet
-
Abivax SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ABVX. The last closing price for Abivax was US$6,37. Over the last year, Abivax shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Abivax currently has 62.917.479 shares in issue. The market capitalisation of Abivax is US$400,78 million. Abivax has a price to earnings ratio (PE ratio) of -2.64.

ABVX Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Januar 2025
Edgar (US Regulatory)

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224...

09 Januar 2025
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Dezember 2024
Edgar (US Regulatory)

Abivax Announces a Change to the Composition of its Board of Directors

Abivax Announces a Change to the Composition of its Board of Directors PARIS, France, December 23, 2024, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the...

23 Dezember 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

27 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 November 2024
Edgar (US Regulatory)

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

19 November 2024
GlobeNewswire Inc.

Form F-3 - Registration statement by foreign private issuers

19 November 2024
Edgar (US Regulatory)

Abivax presents third quarter 2024 key financial information

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

14 November 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ABVX - Frequently Asked Questions (FAQ)

What is the current Abivax share price?
The current share price of Abivax is US$ 6,23
How many Abivax shares are in issue?
Abivax has 62.917.479 shares in issue
What is the market cap of Abivax?
The market capitalisation of Abivax is USD 400,78M
What is the 1 year trading range for Abivax share price?
Abivax has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Abivax?
The price to earnings ratio of Abivax is -2,64
What is the cash to sales ratio of Abivax?
The cash to sales ratio of Abivax is 84,47
What is the reporting currency for Abivax?
Abivax reports financial results in EUR
What is the latest annual turnover for Abivax?
The latest annual turnover of Abivax is EUR 4,62M
What is the latest annual profit for Abivax?
The latest annual profit of Abivax is EUR -147,74M
What is the registered address of Abivax?
The registered address for Abivax is 7-11 BOULEVARD HAUSSMANN, PARIS, PARIS, 75009
What is the Abivax website address?
The website address for Abivax is www.abivax.com
Which industry sector does Abivax operate in?
Abivax operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
ASSTAsset Entities Inc
US$ 1,36
(51,11%)
121,68M
STAIScanTech AI Systems Inc
US$ 2,12
(44,22%)
51,68M
JYDJayud Global Logistics Ltd
US$ 3,53
(42,91%)
1,27M
NTRBNutriband Inc
US$ 7,39
(41,84%)
3,88M
STFSStar Fashion Culture Holdings Ltd
US$ 2,62
(-80,61%)
30,25M
HEPAHepion Pharmaceuticals Inc
US$ 0,135
(-58,05%)
39,89M
STBXStarBox Group Holdings Ltd
US$ 0,6201
(-36,50%)
1,63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93,51
(-35,73%)
1
JUNSJupiter Neurosciences Inc
US$ 3,61
(-33,39%)
6,87M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6446
(30,75%)
296,43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3191
(33,57%)
229,11M
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
NVDANVIDIA Corporation
US$ 147,07
(4,43%)
216,62M
RGTIRigetti Computing Inc
US$ 13,89
(-0,64%)
154,54M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ABVX
Abivax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten